What is the AIM regimen for the treatment of metastatic soft tissue sarcoma treatment?

Updated: Apr 29, 2019
  • Author: from Memorial Sloan-Kettering - Mrinal M Gounder, MD; Chief Editor: Edwin Choy, MD, PhD  more...
  • Print


Doxorubicin 20-25 mg/m2 IV push on days 1-3 plus

Ifosfamide 2000-3000 mg/m2 IV push bolus 3 h on days 1-3 plus

Mesna 225 mg/m2 IV over 1 h before ifosfamide and at 4 and 8 h after ifosfamide

Repeat every 21-28 d

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!